Amiodarone Hydrochloride Injection, USP, 450 mg per 9 mL (50 mg / mL), 9 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-181-09
Published December 4, 2019 · Recall initiated: November 11, 2019
Summary
FDA records drug Class III recall D-0521-2020, published December 4, 2019 and initiated November 11, 2019. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 29,830 vials; Lot: Lot# CAH180001, exp. date Jan 2020; CAH180003, exp. date Feb 2020; CAH180011, CAH180012, exp. date Jun 2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization: Presence of visible particulate matter.
What to do
Voluntary: Firm initiated · Letter
Get an email if AMIODARONE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AMIODARONE HYDROCHLORIDE
- Manufacturer
- AuroMedics Pharma LLC
- Distributor
- Distributed Nationwide in the US
- UPC
- 0355150180035
- Lot
- Lot# CAH180001, exp. date Jan 2020; CAH180003, exp. date Feb 2020; CAH180011, CAH180012, exp. date Jun 2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAmiodarone Hydrochloride Injection, USP, 450 mg/9 mL (50 mg/mL), 9 mL Single-Dose Vial (NDC 67457-153-99); 10September 9, 2020
- FDAAmiodarone Hydrochloride Injection, USP, 150 mg per 3 mL (50 mg / mL), 3 mL Single Dose Vial, Rx only,December 4, 2019
- FDAAVKARE Ranitidine Tablets, USP 150 mg Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478 ManufacturedDecember 4, 2019
- FDAAVKARE Ranitidine Tablets, USP 300 mg Rx Only NDC Manufactured for: AvKARE, Inc. Pulaski, TN 38478 a) 250December 4, 2019
- FDABIOFLO 8F SINGLE PLASTIC FILLED; VALVED, UPN H965440220, Cat. No. 44-022November 27, 2019
- FDAAmiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx only, Manufactured for MylanOctober 15, 2014
Questions about this recall
Was Amiodarone Hydrochloride Injection, USP, 450 mg per 9 mL (50 mg / mL), 9 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-181-09 recalled?
Yes. FDA published recall D-0521-2020 on December 4, 2019. Reported hazard: Crystallization: Presence of visible particulate matter.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AMIODARONE HYDROCHLORIDE. UPC: 0355150180035.